Office of the United States Trade Representative
05/23/2025 | Press release | Distributed by Public on 05/23/2025 13:36
USTR Seeks Comments Regarding Foreign Nations Freeloading on American-Financed Innovation
WASHINGTON - Pursuant Executive Order 14297, titled Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, the Office of the United States Trade Representative invites comments from interested parties regarding any act, policy, or practice that may be unreasonable or discriminatory and that has the effect of forcing American patients to pay for a disproportionate amount of global pharmaceutical research and development, including by suppressing the price of pharmaceutical products below fair market value in foreign countries.
To be assured of consideration, please submit comments by June 27, 2025.
To view the Federal Register Notice, click here.
Comments in response to this notice can be submitted or accessed here.
###
Office of the United States Trade Representative published this content on May 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 23, 2025 at 19:36 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io